1. © 2011 TRIO GRUP 2. TRIO GRUP CLINICALRESEARCH (CRO)Established in 2011TRIO GRUP headquarter is in Ankara, TURKEYApproved by Turkish regulatory authority Ministry…

1. Quality by Design HighlightsAnalytical Method Guidelines, Transfer,System Suitability, Traceability, andVariability MinimizationBy Satendra Kumar Vishwakarma, PhD 2. Declaration…

1. Regulatory and QA Considerations for Drug Product Development Louise Johnson, M.S. Chinese American Biopharmaceutical Society Meeting June 5, 2010 2. Core Principles Patient…

1. Avaali Solutions Pvt. Ltd. (www.avaali.com) 2. About AvaaliWho we are • Founded in 2012; started operations in January 2013 • Private Limited company under Indian…

1. Journal of Advanced Pharmaceutical Technology & Research • Volume 5 • Issue 1 • January-March 2014 • Pages 1-***JAPTRISSN 2231-4040Journal of Advanced Pharmaceutical…

1. A decade of eCTD: time to rejuvenate!Michiel Stam Manager Regulatory Operations Qdossier B.V. 2. Agenda Introduction Continuous challenges Regulatory guidance and specifications…

Slide 1How to Validate a Vendor Purchased Application Presented by: Lisa Morton, Matt Ferdock DataCeutics, Inc. Presented for: Oracle Clinical User Group 4th Annual Meeting,…

Slide 1Monika Kawohl Principal Statistical Programmer Accovion GmbH, Marburg, Germany New FDA Documents - Discussion of Implementation Considerations Slide 2 German Speaking…

Slide 1Analysis Databases: A Regulatory Perspective 2003 FDA/Industry Statistics Workshop "Statistics: From Theory to Regulatory Acceptance Parallel Session II: Analysis…

Slide 1Dr M. Moshiri Slide 2 In vitro genetic toxicity tests, concerned with the genetic effects of toxic materials in vitro, are the forerunner of all in vitro toxicity…